A world-renowned animal cancer specialist is to collaborate with UK vets and share his expertise during a sabbatical with Fitzpatrick Referrals Oncology and Soft Tissue Hospital.
Jonathan Bray, an associate professor in companion animal clinical studies and head of the companion animal group at Massey University in New Zealand, hopes his stay in England will also provide opportunities for him to learn from the UK clinical teams.
He also hopes the collaboration will lead to enhanced veterinary knowledge on all sides and improved animal health and welfare.
Prof Bray said: “After several years of juggling clinical commitments, administration and various HR challenges, I felt I needed some ‘me’ time.”
He added he, therefore, jumped at the chance to spend a three-month sabbatical at Fitzpatrick Referrals.
Prof Bray said he was really looking forward to joining the team as consultant surgeon, getting back into a busy clinical environment and regaining experience with some of the more complicated and challenging resections.
He said: “My clinical passion is oncology and soft tissue surgery, and what Nick Bacon and Noel Fitzpatrick are trying to create here sounds really exciting.
“I firmly believe optimal treatment of both advanced and uncommon companion animal oncological conditions is best achieved within a dedicated multidisciplinary unit, as is the case in human medicine.”
Prof Bray added: “These oncology units are composed of integrated teams of surgeons, medical and radiation oncologists, nurses and technicians who share a common philosophy in regard to patient and client care and management.
“The benefit of a multi-modality approach is it ensures a patient is managed with a protocol devised for each patient, based on its presentation and type of cancer condition.”
He is also looking forward to working with Prof Fitzpatrick on prosthetic work and exchanging views on emerging technologies developed at Fitzpatrick Referrals and in New Zealand, including patient-specific implants for mandibular radial and tibial tumours in cats and dogs.
Prof Bray added: “This is a very exciting field and promises enormous benefits for patients with bone cancer, who would otherwise suffer functional loss through amputation.”
- Read our full, exclusive interview with Prof Bray in the 5 December issue of Veterinary Times.